Anti-inflammatory dietary combo in overweight and obese women with polycystic ovary syndrome
Not Applicable
- Conditions
- Fertility-femalepolycystic ovary syndrome
- Registration Number
- PACTR201502001001110
- Lead Sponsor
- amany salama
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Non-pregnant, overweight and obese adult females with PCOS, aged 20 ¿ 40 years
Exclusion Criteria
The following subjects were excluded from the study:
¿ Subjects having type 1 or type 2 diabetes.
¿ Subjects receiving metformin within the last month.
¿ Subjects receiving ovulation induction medications within the last month.
¿ Subjects following a diet regimen within the last month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie anti-inflammatory diet effects in PCOS patients with metabolic syndrome?
How does anti-inflammatory diet compare to metformin in improving insulin resistance in PCOS?
Which inflammatory biomarkers predict response to dietary interventions in PCOS?
What are the potential adverse events of combining anti-inflammatory diets with metformin in PCOS?
Are there synergistic effects between anti-inflammatory diets and other PCOS treatments like GLP-1 agonists?